| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0B | $7.0B | $5.9B | $4.4B | $2.9B | $0.6B | $0.6B | $0.6B |
| Cost of Revenue | $3.2B | $2.5B | $2.2B | $1.7B | $1.1B | $0.2B | $0.2B | $0.2B |
| Gross Profit | $5.8B | $4.5B | $3.6B | $2.7B | $1.9B | $0.4B | $0.4B | $0.4B |
| R&D Expense | $1.2B | $1.0B | $0.9B | $0.7B | $0.6B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.9B | $2.9B | $2.3B | $1.5B | $0.9B | $0.2B | $0.2B | $0.2B |
| Net Income | $3.5B | $2.9B | $2.1B | $1.4B | $0.8B | $0.2B | $0.3B | $0.2B |
| EPS (Basic) | $2.79 | $2.27 | $6.75 | $4.41 | $2.74 | $2.41 | $3.41 | $2.26 |
| EPS (Diluted) | $2.75 | $2.23 | $6.58 | $4.27 | $2.63 | $2.31 | $3.25 | $2.10 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.4B | $14.0B | $9.9B | $6.8B | $5.7B | $4.7B | $4.2B | $3.1B |
| Current Assets | $16.4B | $11.9B | $8.4B | $5.6B | $4.8B | $3.8B | $3.5B | $2.7B |
| Cash & Equivalents | $2.0B | $2.8B | $1.9B | $0.7B | $0.6B | $0.9B | $1.1B | $0.6B |
| Total Liabilities | $7.1B | $4.0B | $2.7B | $1.9B | $1.8B | $1.4B | $1.3B | $0.9B |
| Current Liabilities | $5.4B | $2.7B | $1.9B | $1.3B | $1.1B | $0.8B | $0.6B | $0.6B |
| Stockholders' Equity | $12.4B | $10.0B | $7.2B | $4.9B | $4.0B | $3.3B | $2.9B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.4B | $3.7B | $2.0B | $0.5B | $1.0B | $0.7B | $1.0B | $0.5B |
| Investing Cash Flow | $-3.6B | $-2.5B | $-0.7B | $0.2B | $-0.9B | $-0.6B | $-0.3B | $-0.8B |
| Capital Expenditures | — | — | — | — | — | — | $0.0B | $0.0B |
| Financing Cash Flow | $-1.6B | $-0.4B | $-0.1B | $-0.7B | $-0.4B | $-0.3B | $-0.2B | $0.0B |